Enhancement of infectious bovine keratoconjunctivitis by modified-live infectious bovine rhinotracheitis virus vaccine.
The effects of a modified-live infectious bovine rhinotracheitis virus vaccine (administered ocularly or intranasally) on experimentally induced infectious bovine keratoconjunctivitis were evaluated. The modified-live infectious bovine rhinotracheitis virus vaccine was administered to 13 male Holstein calves (intranasally in 4 and ocularly in 9; day 0). Five calves were not vaccinated and served as controls. Calves were examined daily and, starting on day 4, Moraxella bovis was administered ocularly to all 18 calves once daily for 4 days. The eyes of all calves were assigned a clinical score, and the ocular secretions were evaluated for presence of infectious bovine rhinotracheitis virus and M bovis daily until day 19. The severity of the ocular lesions was estimated by scoring the lesions clinically and by determining the protein concentration, myeloperoxidase activity, and WBC count in the tears. By day 5, conjunctivitis, chemosis, and epiphora were observed in all of the calves vaccinated ocularly. The calves vaccinated intranasally developed conjunctival plaques, but did not develop chemosis or photophobia. All of the calves developed keratitis after inoculation with M bovis. The median lesion scores were greater in both groups of vaccinated calves than in the controls. Corneal perforations developed exclusively in the vaccinated calves. The frequency of M bovis isolation from ocular secretions was significantly (P less than 0.05) greater in the vaccinated calves than in the controls. The tears from the intranasally vaccinated calves contained the highest myeloperoxidase activity and WBC count. The mean protein concentration in the tears of vaccinated calves was not significantly different from that in tears of controls.(ABSTRACT TRUNCATED AT 250 WORDS)
George
L W
LW
Department of Medicine, School of Veterinary Medicine, University of California, Davis 95616.
Ardans
A
A
Mihalyi
J
J
Guerra
M R
MR
D000818:Animals; D002417:Cattle; D015169:Colony Count, Microbial; D003228:Conjunctiva / Q000473:pathology; D003315:Cornea / Q000473:pathology; D003320:Corneal Ulcer / Q000209:etiology / Q000662:veterinary; D007242:Herpesvirus 1, Bovine / Q000254:growth & development / Q000276:immunology*; D007639:Keratoconjunctivitis, Infectious / Q000209:etiology*; D007958:Leukocyte Count / Q000662:veterinary; D008213:Lymphocyte Activation; D008297:Male; D009016:Moraxella; D013666:Tears / Q000166:cytology; D014611:Vaccination / Q000009:adverse effects / Q000662:veterinary*; D014613:Vaccines, Attenuated / Q000009:adverse effects; D014765:Viral Vaccines / Q000009:adverse effects*
D014613:Vaccines, Attenuated; D014765:Viral Vaccines